{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:43:48Z","timestamp":1791917028822,"version":"4.3.4"},"reference-count":160,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:00:00Z","timestamp":1772064000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>Bone metastasis is a highly prevalent complication in patients with advanced prostate, breast, and lung cancers, which significantly affects the patient\u2019s prognosis. In recent years, the integration of multi-omics technologies has provided unprecedented insights into the systematic analysis of the highly heterogeneous tumor microenvironment at a systemic level. This review begins with a cross-cancer comparison, systematically outlining the functional similarities and differences in key microenvironment components (e.g., tumor-associated macrophages, cancer-associated fibroblasts, osteoclasts, and T cells) in bone metastasis across these three cancer types. It emphasizes how miRNAs mediate intercellular communication via exosomes to coordinately regulate immune evasion, stromal activation, and bone metabolic reprogramming. We further explored the translational potential of miRNA-based liquid biopsies (e.g., miR-141-3p and miR-34a) for diagnosing and prognosticating bone metastasis in breast, prostate, and lung cancers. Finally, this article looks ahead at how integrating multi-omics data with AI predictive models can overcome current delivery and safety challenges, advancing miRNA research towards the ultimate goal of precision medicine.<\/jats:p>","DOI":"10.3389\/fonc.2026.1775016","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:29:47Z","timestamp":1772083787000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of MiRNA-mediated tumor microenvironment in bone metastasis from a multi-omics perspective: cross-cancer mechanisms and clinical translation"],"prefix":"10.3389","volume":"16","author":[{"given":"Zhuo","family":"Gu","sequence":"first","affiliation":[{"name":"Department of Orthopaedics, Inner Mongolia Autonomous Region People\u2019s Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-fen","family":"Zhu","sequence":"additional","affiliation":[{"name":"Physical Examination Center, Affiliated Hospital of Inner Mongolia Medical University","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng-fei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Inner Mongolia Autonomous Region People\u2019s Hospital","place":["Hohhot, Inner Mongolia, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,26]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cells10061377","article-title":"Breast cancer with bone metastasis: molecular insights and clinical management","volume":"10","author":"Venetis","year":"2021","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1007\/s00261-016-0851-3","article-title":"Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis","volume":"42","author":"Vargas","year":"2017","journal-title":"Abdominal Radiol (New York)"},{"key":"B3","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.lungcan.2014.07.020","article-title":"Metastatic sites and survival in lung cancer","volume":"86","author":"Riihim\u00e4ki","year":"2014","journal-title":"Lung Cancer (Amsterdam Netherlands)"},{"key":"B4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1038\/s41572-020-00216-3","article-title":"Bone metastases","volume":"6","author":"Coleman","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11022.x","article-title":"Expression of microRNAs in basal cell carcinoma","volume":"167","author":"Sand","year":"2012","journal-title":"Br J Dermatol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","article-title":"Tumor microenvironment as a therapeutic target in cancer","volume":"221","author":"Xiao","year":"2021","journal-title":"Pharmacol Ther"},{"key":"B7","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1186\/s12967-023-04437-4","article-title":"Application of radiomics-based multiomics combinations in the tumor microenvironment and cancer prognosis","volume":"21","author":"Kang","year":"2023","journal-title":"J Trans Med"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1089\/omi.2021.0087","article-title":"MicroRNA interactome multiomics characterization for cancer research and personalized medicine: an expert review","volume":"25","author":"Sindhu","year":"2021","journal-title":"Omics: J Integr Biol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.08.034","article-title":"MicroRNA","volume":"141","author":"Lu","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27486","article-title":"An overview of microRNAs: Biology, functions, therapeutics, and analysis methods","volume":"234","author":"Saliminejad","year":"2019","journal-title":"J Cell Physiol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1552902","article-title":"MicroRNAs in bone metastases: mechanisms and research progression","volume":"15","author":"He","year":"2025","journal-title":"Front Oncol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-023-01491-0","article-title":"MicroRNAs mediated interaction of tumor microenvironment cells with breast cancer cells during bone metastasis","volume":"30","author":"Akshaya","year":"2023","journal-title":"Breast Cancer (Tokyo Japan)"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1580314","article-title":"The role and mechanisms of exosome microRNA in regulating metastasis within the tumor microenvironment of prostate cancer","volume":"15","author":"Song","year":"2025","journal-title":"Front Oncol"},{"key":"B14","doi-asserted-by":"publisher","first-page":"3046379","DOI":"10.1155\/2019\/3046379","article-title":"The interplay between microRNAs and cellular components of tumour microenvironment (TME) on non-small-cell lung cancer (NSCLC) progression","volume":"2019","author":"Lee","year":"2019","journal-title":"J Immunol Res"},{"key":"B15","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1186\/s13046-022-02520-0","article-title":"Osteoblasts and osteoclasts: an important switch of tumour cell dormancy during bone metastasis","volume":"41","author":"Dai","year":"2022","journal-title":"J Exp Clin Cancer Res: CR"},{"key":"B16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1152\/physrev.00012.2019","article-title":"Bone metastasis: mechanisms, therapies, and biomarkers","volume":"101","author":"Cl\u00e9zardin","year":"2021","journal-title":"Physiol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.864739","article-title":"Dual relationship between stromal cells and immune cells in the tumor microenvironment","volume":"13","author":"Mun","year":"2022","journal-title":"Front Immunol"},{"key":"B18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.semcancer.2022.12.009","article-title":"Artificial intelligence-based multi-omics analysis fuels cancer precision medicine","volume":"88","author":"He","year":"2023","journal-title":"Semin Cancer Biol"},{"key":"B19","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41586-020-1969-6","article-title":"Pan-cancer analysis of whole genomes","volume":"578","year":"2020","journal-title":"Nature"},{"key":"B20","doi-asserted-by":"publisher","first-page":"aad6933","DOI":"10.1126\/science.aad6933","article-title":"Nongenetic functions of the genome","volume":"352","author":"Bustin","year":"2016","journal-title":"Sci (New York NY)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/j.ejca.2021.03.005","article-title":"Applications of single-cell and bulk RNA sequencing in onco-immunology","volume":"149","author":"Kuksin","year":"2021","journal-title":"Eur J Cancer (Oxford England: 1990)"},{"key":"B22","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41368-021-00146-0","article-title":"From bulk, single-cell to spatial RNA sequencing","volume":"13","author":"Li","year":"2021","journal-title":"Int J Oral Sci"},{"key":"B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41576-020-0265-5","article-title":"Integrating genetic and non-genetic determinants of cancer evolution by single-cell multi-omics","volume":"22","author":"Nam","year":"2021","journal-title":"Nat Rev Genet"},{"key":"B24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41592-019-0703-5","article-title":"Method of the Year 2019: Single-cell multimodal omics","volume":"17","year":"2020","journal-title":"Nat Methods"},{"key":"B25","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1038\/s41598-025-85531-z","article-title":"Single-cell profiling transcriptomic reveals cellular heterogeneity and cellular crosstalk in breast cancer lymphatic node, bone, and brain metastases","volume":"15","author":"Zhu","year":"2025","journal-title":"Sci Rep"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s12094-024-03594-2","article-title":"Unraveling the metastatic niche in breast cancer bone metastasis through single-cell RNA sequencing","volume":"27","author":"Li","year":"2025","journal-title":"Clin Trans Oncol"},{"key":"B27","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1016\/j.ccell.2021.09.005","article-title":"Human prostate cancer bone metastases have an actionable immunosuppressive microenvironment","volume":"39","author":"Kfoury","year":"2021","journal-title":"Cancer Cell"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13040909","article-title":"Comprehensive integrated analysis reveals the spatiotemporal microevolution of cancer cells in patients with bone-metastatic prostate cancer","volume":"13","author":"Feng","year":"2025","journal-title":"Biomedicines"},{"key":"B29","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.cell.2018.05.060","article-title":"Single-cell map of diverse immune phenotypes in the breast tumor microenvironment","volume":"174","author":"Azizi","year":"2018","journal-title":"Cell"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1038\/s41577-019-0127-6","article-title":"Macrophages as regulators of tumour immunity and immunotherapy","volume":"19","author":"DeNardo","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.13158","article-title":"Clinical and biological relevance of the transcriptomic-based prostate cancer metastasis subtypes MetA-C","volume":"16","author":"Thysell","year":"2022","journal-title":"Mol Oncol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/1878-0261.12526","article-title":"Gene expression profiles define molecular subtypes of prostate cancer bone metastases with different outcomes and morphology traceable back to the primary tumor","volume":"13","author":"Thysell","year":"2019","journal-title":"Mol Oncol"},{"key":"B33","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s10585-025-10365-y","article-title":"Morphological heterogeneities in prostate cancer bone metastases are related to molecular subtypes and prognosis","volume":"42","author":"Bergstr\u00f6m","year":"2025","journal-title":"Clin Exp Metastasis"},{"key":"B34","doi-asserted-by":"publisher","first-page":"ra89","DOI":"10.1126\/scisignal.2005392","article-title":"The autoinhibitory C-terminal SH2 domain of phospholipase C-\u03b32 stabilizes B cell receptor signalosome assembly","volume":"7","author":"Wang","year":"2014","journal-title":"Sci Signaling"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2005.01.018","article-title":"Autoimmunity and inflammation due to a gain-of-function mutation in phospholipase C gamma 2 that specifically increases external Ca2+ entry","volume":"22","author":"Yu","year":"2005","journal-title":"Immunity"},{"key":"B36","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1007\/s12672-025-02269-w","article-title":"Single-cell profiling uncovers the intricate pathological niche diversity in brain, lymph node, bone, and adrenal metastases of lung cancer","volume":"16","author":"Liu","year":"2025","journal-title":"Discov Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"e13743","DOI":"10.1111\/cpr.13743","article-title":"Single-cell transcriptomic analysis of the senescent microenvironment in bone metastasis","volume":"58","author":"Wang","year":"2025","journal-title":"Cell Prolif"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.741305","article-title":"Tumor-associated macrophages and their functional transformation in the hypoxic tumor microenvironment","volume":"12","author":"He","year":"2021","journal-title":"Front Immunol"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.888713","article-title":"Shaping polarization of tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front Immunol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"289","DOI":"10.2217\/imt-2016-0135","article-title":"Tumor-associated macrophages: implications in cancer immunotherapy","volume":"9","author":"Petty","year":"2017","journal-title":"Immunotherapy"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1680455","article-title":"Immunotherapy strategies targeting tumor-associated macrophages and their mechanisms of action in tumor progression","volume":"16","author":"Zhu","year":"2025","journal-title":"Front Immunol"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22136995","article-title":"Macrophage polarization states in the tumor microenvironment","volume":"22","author":"Boutilier","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2013.258","article-title":"MicroRNA-19a-3p inhibits breast cancer progression and metastasis by inducing macrophage polarization through downregulated expression of Fra-1 proto-oncogene","volume":"33","author":"Yang","year":"2014","journal-title":"Oncogene"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.6284","article-title":"A double feedback loop mediated by microRNA-23a\/27a\/24-2 regulates M1 versus M2 macrophage polarization and thus regulates cancer progression","volume":"7","author":"Ma","year":"2016","journal-title":"Oncotarget"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1111\/1759-7714.14891","article-title":"Tumor-derived exosomal miR-148b-3p mediates M2 macrophage polarization via TSC2\/mTORC1 to promote breast cancer migration and invasion","volume":"14","author":"Hao","year":"2023","journal-title":"Thorac Cancer"},{"key":"B46","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1186\/s12951-023-02190-w","article-title":"Intervening in hnRNPA2B1-mediated exosomal transfer of tumor-suppressive miR-184-3p for tumor microenvironment regulation and cancer therapy","volume":"21","author":"Zhou","year":"2023","journal-title":"J Nanobiotechnol"},{"key":"B47","doi-asserted-by":"publisher","first-page":"126","DOI":"10.3892\/ijo.2022.5416","article-title":"miR-382 inhibits breast cancer progression and metastasis by affecting the M2 polarization of tumor-associated macrophages by targeting PGC-1\u03b1","volume":"61","author":"Zhou","year":"2022","journal-title":"Int J Oncol"},{"key":"B48","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/s13577-025-01232-9","article-title":"Hypoxic breast cancer cell-derived exosomal miR-143-3p targets RICTOR to regulate M2 macrophage polarization, thereby modulating cancer cell invasiveness","volume":"38","author":"Lian","year":"2025","journal-title":"Hum Cell"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.01167","article-title":"Exosomal microRNAs as mediators of cellular interactions between cancer cells and macrophages","volume":"11","author":"Kwon","year":"2020","journal-title":"Front Immunol"},{"key":"B50","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1186\/s12967-022-03780-2","article-title":"Monocytes educated by cancer-associated fibroblasts secrete exosomal miR-181a to activate AKT signaling in breast cancer cells","volume":"20","author":"Pakravan","year":"2022","journal-title":"J Trans Med"},{"key":"B51","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/978-3-030-65768-0_14","article-title":"Metabolic relationship between cancer-associated fibroblasts and cancer cells","volume":"1311","author":"Sazeides","year":"2021","journal-title":"Adv Exp Med Biol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2014-202561","article-title":"Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology","volume":"67","author":"Valcz","year":"2014","journal-title":"J Clin Pathol"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmed.2013.05.004","article-title":"\u2018Cancer associated fibroblasts\u2019--more than meets the eye","volume":"19","author":"Madar","year":"2013","journal-title":"Trends Mol Med"},{"key":"B54","doi-asserted-by":"publisher","first-page":"e12376","DOI":"10.1002\/2056-4538.12376","article-title":"Recurrent and novel fusions detected by targeted RNA sequencing as part of the diagnostic workflow of soft tissue and bone tumours","volume":"10","author":"Baltazar","year":"2024","journal-title":"J Pathol Clin Res"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2015.1071742","article-title":"Hierarchical paracrine interaction of breast cancer associated fibroblasts with cancer cells via hMAPK-microRNAs to drive ER-negative breast cancer phenotype","volume":"16","author":"Shah","year":"2015","journal-title":"Cancer Biol Ther"},{"key":"B56","doi-asserted-by":"publisher","first-page":"109009","DOI":"10.1016\/j.celrep.2021.109009","article-title":"Contextual cues from cancer cells govern cancer-associated fibroblast heterogeneity","volume":"35","author":"Bota-Rabassedas","year":"2021","journal-title":"Cell Rep"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-019-0566-7","article-title":"MicroRNA-222 reprogrammed cancer-associated fibroblasts enhance growth and metastasis of breast cancer","volume":"121","author":"Chatterjee","year":"2019","journal-title":"Br J Cancer"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.14752","article-title":"Cancer-associated fibroblasts release exosomal microRNAs that dictate an aggressive phenotype in breast cancer","volume":"8","author":"Donnarumma","year":"2017","journal-title":"Oncotarget"},{"key":"B59","doi-asserted-by":"publisher","first-page":"111182","DOI":"10.1016\/j.cellsig.2024.111182","article-title":"Exosomal miRNA-92a derived from cancer-associated fibroblasts promote invasion and metastasis in breast cancer by regulating G3BP2","volume":"119","author":"Sheng","year":"2024","journal-title":"Cell Signal"},{"key":"B60","doi-asserted-by":"publisher","first-page":"5266627","DOI":"10.1155\/2022\/5266627","article-title":"Breast cancer exosome-derived miR-425-5p induces cancer-associated fibroblast-like properties in human mammary fibroblasts by TGF\u03b21\/ROS signaling pathway","volume":"2022","author":"Zhu","year":"2022","journal-title":"Oxid Med Cell Longev"},{"key":"B61","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.02026","article-title":"Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92\/PD-L1 Pathway","volume":"11","author":"Dou","year":"2020","journal-title":"Front Immunol"},{"key":"B62","doi-asserted-by":"publisher","first-page":"e70471","DOI":"10.1096\/fj.202402024RRR","article-title":"CAF-derived exosomal LINC01711 promotes breast cancer progression by activating the miR-4510\/NELFE axis and enhancing glycolysis","volume":"39","author":"Tao","year":"2025","journal-title":"FASEB J"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1162-2","article-title":"FAK signaling in cancer-associated fibroblasts promotes breast cancer cell migration and metastasis by exosomal miRNAs-mediated intercellular communication","volume":"39","author":"Wu","year":"2020","journal-title":"Oncogene"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.3390\/cells9092143","article-title":"miR-9-mediated inhibition of EFEMP1 contributes to the acquisition of pro-tumoral properties in normal fibroblasts","volume":"9","author":"Cosentino","year":"2020","journal-title":"Cells"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.7150\/thno.53412","article-title":"Exosomal miR-500a-5p derived from cancer-associated fibroblasts promotes breast cancer cell proliferation and metastasis through targeting USP28","volume":"11","author":"Chen","year":"2021","journal-title":"Theranostics"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.4933","article-title":"miR-146b-5p mediates p16-dependent repression of IL-6 and suppresses paracrine procarcinogenic effects of breast stromal fibroblasts","volume":"6","author":"Al-Ansari","year":"2015","journal-title":"Oncotarget"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2015.78","article-title":"Stromal miR-200s contribute to breast cancer cell invasion through CAF activation and ECM remodeling","volume":"23","author":"Tang","year":"2016","journal-title":"Cell Death Differ"},{"key":"B68","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.tips.2018.10.008","article-title":"MDSC; the most important cell you have never heard of","volume":"40","author":"Tesi","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.20892\/j.issn.2095-3941.2020.0806","article-title":"Targeting myeloid-derived suppressor cells for cancer therapy","volume":"18","author":"Tang","year":"2021","journal-title":"Cancer Biol Med"},{"key":"B70","doi-asserted-by":"publisher","first-page":"12150","DOI":"10.1038\/ncomms12150","article-title":"Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards","volume":"7","author":"Bronte","year":"2016","journal-title":"Nat Commun"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.7150","article-title":"Loss of oncogenic miR-155 in tumor cells promotes tumor growth by enhancing C\/EBP-\u03b2-mediated MDSC infiltration","volume":"7","author":"Kim","year":"2016","journal-title":"Oncotarget"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiad020","article-title":"SOCS3 deficiency-dependent autophagy repression promotes the survival of early-stage myeloid-derived suppressor cells in breast cancer by activating the Wnt\/mTOR pathway","volume":"113","author":"Zhang","year":"2023","journal-title":"J Leukocyte Biol"},{"key":"B73","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2016.229","article-title":"Exosomes miR-126a released from MDSC induced by DOX treatment promotes lung metastasis","volume":"36","author":"Deng","year":"2017","journal-title":"Oncogene"},{"key":"B74","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/omi.12195","article-title":"The function of dendritic cells in modulating the host response","volume":"33","author":"Song","year":"2018","journal-title":"Mol Oral Microbiol"},{"key":"B75","doi-asserted-by":"publisher","DOI":"10.1038\/s41423-023-00990-6","article-title":"Dendritic cell subsets in cancer immunity and tumor antigen sensing","volume":"20","author":"Prete","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1080\/08820139.2020.1801721","article-title":"Upregulation of microRNA-155 enhanced migration and function of dendritic cells in three-dimensional breast cancer microenvironment","volume":"50","author":"Yang","year":"2021","journal-title":"Immunol Invest"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e0121510","DOI":"10.1371\/journal.pone.0121510","article-title":"MicroRNA-22 impairs anti-tumor ability of dendritic cells by targeting p38","volume":"10","author":"Liang","year":"2015","journal-title":"PloS One"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-020-02507-w","article-title":"miRNA-5119 regulates immune checkpoints in dendritic cells to enhance breast cancer immunotherapy","volume":"69","author":"Zhang","year":"2020","journal-title":"Cancer Immunol Immunother: CII"},{"key":"B79","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.smim.2018.02.002","article-title":"The dark side of tumor-associated endothelial cells","volume":"35","author":"Sanctis","year":"2018","journal-title":"Semin Immunol"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-011-0723-7","article-title":"Endothelial-specific intron-derived miR-126 is down-regulated in human breast cancer and targets both VEGFA and PIK3R2","volume":"351","author":"Zhu","year":"2011","journal-title":"Mol Cell Biochem"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.00680","article-title":"The pivotal role of regulatory T cells in the regulation of innate immune cells","volume":"10","author":"Okeke","year":"2019","journal-title":"Front Immunol"},{"key":"B82","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1146\/annurev-cancerbio-042920-104912","article-title":"The multifaceted role of regulatory T cells in breast cancer","volume":"5","author":"Kos","year":"2021","journal-title":"Annu Rev Cancer Biol"},{"key":"B83","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/cas.14764","article-title":"Concomitant overexpression of mir-182-5p and mir-182-3p raises the possibility of IL-17-producing Treg formation in breast cancer by targeting CD3d, ITK, FOXO1, and NFATs: A meta-analysis and experimental study","volume":"112","author":"Soheilifar","year":"2021","journal-title":"Cancer Sci"},{"key":"B84","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.ijbiomac.2018.06.033","article-title":"LncRNA SNHG1 regulates the differentiation of Treg cells and affects the immune escape of breast cancer via regulating miR-448\/IDO","volume":"118","author":"Pei","year":"2018","journal-title":"Int J Biol Macromol"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1038\/icb.2015.37","article-title":"MiR-21 controls in situ expansion of CCR6+ regulatory T cells through PTEN\/AKT pathway in breast cancer","volume":"93","author":"Hu","year":"2015","journal-title":"Immunol Cell Biol"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2012.444","article-title":"Breast tumor-associated osteoblast-derived CXCL5 increases cancer progression by ERK\/MSK1\/Elk-1\/snail signaling pathway","volume":"32","author":"Hsu","year":"2013","journal-title":"Oncogene"},{"key":"B87","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s13058-018-1059-y","article-title":"Metastatic breast cancer cells overexpress and secrete miR-218 to regulate type I collagen deposition by osteoblasts","volume":"20","author":"Liu","year":"2018","journal-title":"Breast Cancer Res: BCR"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1111\/bph.14836","article-title":"Non-coding RNAs in bone remodelling and bone metastasis: Mechanisms of action and translational relevance","volume":"178","author":"Puppo","year":"2021","journal-title":"Br J Pharmacol"},{"key":"B89","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s12943-017-0746-0","article-title":"microRNA-124 inhibits bone metastasis of breast cancer by repressing Interleukin-11","volume":"17","author":"Cai","year":"2018","journal-title":"Mol Cancer"},{"key":"B90","doi-asserted-by":"publisher","first-page":"97","DOI":"10.3892\/ijo.2021.5277","article-title":"Regulatory roles of miRNAs 16, 133a, and 223 on osteoclastic bone destruction caused by breast cancer metastasis","volume":"59","author":"Kitayama","year":"2021","journal-title":"Int J Oncol"},{"key":"B91","doi-asserted-by":"publisher","first-page":"5196","DOI":"10.1038\/s41467-021-25473-y","article-title":"Exosomal miR-19a and IBSP cooperate to induce osteolytic bone metastasis of estrogen receptor-positive breast cancer","volume":"12","author":"Wu","year":"2021","journal-title":"Nat Commun"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.7150\/thno.45351","article-title":"Breast cancer exosomes contribute to pre-metastatic niche formation and promote bone metastasis of tumor cells","volume":"11","author":"Yuan","year":"2021","journal-title":"Theranostics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"84","DOI":"10.3892\/ijmm.2023.5287","article-title":"RAS-stimulated release of exosomal miR-494-3p promotes the osteolytic bone metastasis of breast cancer cells","volume":"52","author":"Kim","year":"2023","journal-title":"Int J Mol Med"},{"key":"B94","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1001\/jama.2018.19323","article-title":"Breast cancer treatment: A review","volume":"321","author":"Waks","year":"2019","journal-title":"JAMA"},{"key":"B95","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1186\/s12967-025-06156-4","article-title":"Tumor-derived exosomal lncRNA-MIR193BHG promotes bone metastasis of breast cancer by targeting the miR-489-3p\/DNMT3A signaling axis in osteoclasts","volume":"23","author":"Liu","year":"2025","journal-title":"J Trans Med"},{"key":"B96","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29784","article-title":"Tumor-associated macrophages promote prostate cancer progression via exosome-mediated miR-95 transfer","volume":"235","author":"Guan","year":"2020","journal-title":"J Cell Physiol"},{"key":"B97","doi-asserted-by":"publisher","DOI":"10.1007\/s11010-023-04854-5","article-title":"Exosome miRNA-203 promotes M1 macrophage polarization and inhibits prostate cancer tumor progression","volume":"479","author":"Zhang","year":"2024","journal-title":"Mol Cell Biochem"},{"key":"B98","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1186\/s12935-020-01563-7","article-title":"Inhibition of let-7b-5p contributes to an anti-tumorigenic macrophage phenotype through the SOCS1\/STAT pathway in prostate cancer","volume":"20","author":"Rong","year":"2020","journal-title":"Cancer Cell Int"},{"key":"B99","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/s41417-024-00742-2","article-title":"Cancer-associated fibroblast exosomes promote prostate cancer metastasis through miR-500a-3p\/FBXW7\/HSF1 axis under hypoxic microenvironment","volume":"31","author":"Liu","year":"2024","journal-title":"Cancer Gene Ther"},{"key":"B100","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.30435","article-title":"Fibroblast-derived exosomal microRNA regulates NKX3-1 expression in androgen-sensitive, androgen receptor-dependent prostate cancer cells","volume":"124","author":"Matsuda","year":"2023","journal-title":"J Cell Biochem"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-020-0431-z","article-title":"Cancer-associated fibroblast-secreted exosomal miR-423-5p promotes chemotherapy resistance in prostate cancer by targeting GREM2 through the TGF-\u03b2 signaling pathway","volume":"52","author":"Shan","year":"2020","journal-title":"Exp Mol Med"},{"key":"B102","doi-asserted-by":"publisher","DOI":"10.1159\/000430313","article-title":"MiR-323 inhibits prostate cancer vascularization through adiponectin receptor","volume":"36","author":"Gao","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"B103","doi-asserted-by":"publisher","DOI":"10.1159\/000491909","article-title":"MiR-195\/-16 family enhances radiotherapy via T cell activation in the tumor microenvironment by blocking the PD-L1 immune checkpoint","volume":"48","author":"Tao","year":"2018","journal-title":"Cell Physiol Biochem"},{"key":"B104","doi-asserted-by":"publisher","first-page":"9636897211052977","DOI":"10.1177\/09636897211052977","article-title":"Exosomal miR-1275 secreted by prostate cancer cells modulates osteoblast proliferation and activity by targeting the SIRT2\/RUNX2 cascade","volume":"30","author":"Zou","year":"2021","journal-title":"Cell Transplant"},{"key":"B105","doi-asserted-by":"publisher","first-page":"195","DOI":"10.4103\/aja202351","article-title":"Knocking down AR promotes osteoblasts to recruit prostate cancer cells by altering exosomal circ-DHPS\/miR-214-3p\/CCL5 pathway","volume":"26","author":"Yang","year":"2024","journal-title":"Asian J Androl"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23031285","article-title":"Exosomal miRNAs from prostate cancer impair osteoblast function in mice","volume":"23","author":"Furesi","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.22014","article-title":"Exosomal miR-141-3p regulates osteoblast activity to promote the osteoblastic metastasis of prostate cancer","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"key":"B108","doi-asserted-by":"publisher","first-page":"e70206","DOI":"10.1096\/fj.202401480R","article-title":"Osteoblast-derived exosomal miR-140-3p targets ACER2 and increases the progression of prostate cancer via the AKT\/mTOR pathway-mediated inhibition of autophagy","volume":"38","author":"Liu","year":"2024","journal-title":"FASEB J"},{"key":"B109","doi-asserted-by":"publisher","first-page":"e70091","DOI":"10.1002\/jev2.70091","article-title":"Extracellular vesicles from prostate cancer-corrupted osteoclasts drive a chain reaction of inflammatory osteolysis and tumour progression at the bone metastatic site","volume":"14","author":"Tamura","year":"2025","journal-title":"J Extracell Vesicles"},{"key":"B110","doi-asserted-by":"publisher","first-page":"8650846","DOI":"10.1155\/2019\/8650846","article-title":"PC-3-derived exosomes inhibit osteoclast differentiation by downregulating miR-214 and blocking NF-\u03baB signaling pathway","volume":"2019","author":"Duan","year":"2019","journal-title":"BioMed Res Int"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1002\/jcb.29401","article-title":"miR-181b\/Oncostatin m axis inhibits prostate cancer bone metastasis via modulating osteoclast differentiation","volume":"121","author":"Han","year":"2020","journal-title":"J Cell Biochem"},{"key":"B112","doi-asserted-by":"publisher","first-page":"e12068","DOI":"10.1002\/jev2.12068","article-title":"Small extracellular vesicles deliver osteolytic effectors and mediate cancer-induced osteolysis in bone metastatic niche","volume":"10","author":"Ma","year":"2021","journal-title":"J Extracell Vesicles"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.1038\/s41417-022-00563-1","article-title":"Cancer-derived exosomal miR-375 targets DIP2C and promotes osteoblastic metastasis and prostate cancer progression by regulating the Wnt signaling pathway","volume":"30","author":"Liu","year":"2023","journal-title":"Cancer Gene Ther"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1717363115","article-title":"Cancer-secreted hsa-miR-940 induces an osteoblastic phenotype in the bone metastatic microenvironment via targeting ARHGAP1 and FAM134A","volume":"115","author":"Hashimoto","year":"2018","journal-title":"Proc Natl Acad Sci United States Am"},{"key":"B115","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1002\/ctm2.493","article-title":"LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p\/runt-related transcription factor 2\/splicing factor proline- and glutamine-rich\/polypyrimidine tract-binding protein 2 axis","volume":"11","author":"Mo","year":"2021","journal-title":"Clin Trans Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1080\/21655979.2022.2076388","article-title":"Knockdown of lncRNA PCAT6 suppresses the growth of non-small cell lung cancer cells by inhibiting macrophages M2 polarization via miR-326\/KLF1 axis","volume":"13","author":"Chen","year":"2022","journal-title":"Bioengineered"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2021.10.045","article-title":"M2 macrophage-derived exosomes promote lung adenocarcinoma progression by delivering miR-942","volume":"526","author":"Wei","year":"2022","journal-title":"Cancer Lett"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.3390\/cells10082091","article-title":"Comprehensive integrative analysis reveals the association of KLF4 with macrophage infiltration and polarization in lung cancer microenvironment","volume":"10","author":"Arora","year":"2021","journal-title":"Cells"},{"key":"B119","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymthe.2017.11.016","article-title":"Hypoxic lung-cancer-derived extracellular vesicle microRNA-103a increases the oncogenic effects of macrophages by targeting PTEN","volume":"26","author":"Hsu","year":"2018","journal-title":"Mol Ther"},{"key":"B120","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.8718","article-title":"miR-1207-5p suppresses lung cancer growth and metastasis by targeting CSF1","volume":"7","author":"Dang","year":"2016","journal-title":"Oncotarget"},{"key":"B121","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.08.013","article-title":"miR-101 represses lung cancer by inhibiting interaction of fibroblasts and cancer cells by down-regulating CXCL12","volume":"74","author":"Zhang","year":"2015","journal-title":"Biomed Pharmacother = Biomed Pharmacother"},{"key":"B122","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.canlet.2021.03.021","article-title":"Cancer-associated fibroblasts activated by miR-196a promote the migration and invasion of lung cancer cells","volume":"508","author":"Lee","year":"2021","journal-title":"Cancer Lett"},{"key":"B123","doi-asserted-by":"publisher","first-page":"e23769","DOI":"10.1002\/jbt.23769","article-title":"Cancer-associated fibroblasts derived exosomal LINC01833 promotes the occurrence of non-small cell lung cancer through miR-335-5p -VAPA axis","volume":"38","author":"Chen","year":"2024","journal-title":"J Biochem Mol Toxicol"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.32604\/or.2024.054141","article-title":"CAF-derived exosome-miR-3124-5p promotes Malignant biological processes in NSCLC via the TOLLIP\/TLR4-MyD88-NF-\u03baB pathway","volume":"33","author":"Sun","year":"2025","journal-title":"Oncol Res"},{"key":"B125","doi-asserted-by":"publisher","DOI":"10.1016\/j.molonc.2016.08.005","article-title":"Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR-155 regulation and TRAIL activation","volume":"10","author":"Zarogoulidis","year":"2016","journal-title":"Mol Oncol"},{"key":"B126","doi-asserted-by":"publisher","first-page":"5241","DOI":"10.1038\/ncomms6241","article-title":"Metastasis is regulated via microRNA-200\/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression","volume":"5","author":"Chen","year":"2014","journal-title":"Nat Commun"},{"key":"B127","doi-asserted-by":"publisher","first-page":"217639","DOI":"10.1016\/j.canlet.2025.217639","article-title":"CircRUNX1 enhances the Warburg effect and immune evasion in non-small cell lung cancer through the miR-145\/HK2 pathway","volume":"620","author":"Li","year":"2025","journal-title":"Cancer Lett"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.27883","article-title":"27-Hydroxycholesterol enhanced osteoclastogenesis in lung adenocarcinoma microenvironment","volume":"234","author":"Zhang","year":"2019","journal-title":"J Cell Physiol"},{"key":"B129","doi-asserted-by":"publisher","first-page":"9836256","DOI":"10.1155\/2018\/9836256","article-title":"Onco-multi-OMICS approach: A new frontier in cancer research","volume":"2018","author":"Chakraborty","year":"2018","journal-title":"BioMed Res Int"},{"key":"B130","doi-asserted-by":"publisher","first-page":"6278","DOI":"10.1038\/s41467-021-26614-z","article-title":"Spatially resolved transcriptomics reveals the architecture of the tumor-microenvironment interface","volume":"12","author":"Hunter","year":"2021","journal-title":"Nat Commun"},{"key":"B131","doi-asserted-by":"publisher","first-page":"123716","DOI":"10.1016\/j.biomaterials.2025.123716","article-title":"Emerging frontiers in microRNA technology: Innovations driving precision medicine","volume":"326","author":"Guo","year":"2025","journal-title":"Biomaterials"},{"key":"B132","doi-asserted-by":"publisher","first-page":"108540","DOI":"10.1016\/j.lungcan.2025.108540","article-title":"Transcriptome analysis reveals crucial oncogenic and tumor suppressor miRNAs in lung adenocarcinoma","volume":"206","author":"Chaturvedi","year":"2025","journal-title":"Lung Cancer (Amsterdam Netherlands)"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics15081028","article-title":"From cell lines to patients: dissecting the proteomic landscape of exosomes in breast cancer","volume":"15","author":"Shefer","year":"2025","journal-title":"Diagn (Basel Switzerland)"},{"key":"B134","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/btz704","article-title":"Spectrum: fast density-aware spectral clustering for single and multi-omic data","volume":"36","author":"John","year":"2020","journal-title":"Bioinf (Oxford England)"},{"key":"B135","doi-asserted-by":"publisher","first-page":"1177932219899051","DOI":"10.1177\/1177932219899051","article-title":"Multi-omics data integration, interpretation, and its application","volume":"14","author":"Subramanian","year":"2020","journal-title":"Bioinf Biol Insights"},{"key":"B136","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12967-024-04864-x","article-title":"Multi-omics integration with weighted affinity and self-diffusion applied for cancer subtypes identification","volume":"22","author":"Duan","year":"2024","journal-title":"J Trans Med"},{"key":"B137","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12911-020-01225-8","article-title":"Deep learning based feature-level integration of multi-omics data for breast cancer patients survival analysis","volume":"20","author":"Tong","year":"2020","journal-title":"BMC Med Inf Decision Making"},{"key":"B138","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s12859-023-05273-5","article-title":"moBRCA-net: a breast cancer subtype classification framework based on multi-omics attention neural networks","volume":"24","author":"Choi","year":"2023","journal-title":"BMC Bioinf"},{"key":"B139","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1038\/s41576-018-0071-5","article-title":"Current and future perspectives of liquid biopsies in genomics-driven oncology","volume":"20","author":"Heitzer","year":"2019","journal-title":"Nat Rev Genet"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-2025-272","article-title":"Development and clinical applications of liquid biopsy assays in cancer screening","volume":"14","author":"Han","year":"2025","journal-title":"Trans Cancer Res"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.3390\/ijms26188944","article-title":"Exploratory Analysis of Circulating Serum miR-197-3p, miR-1236, and miR-1271 Expression in Early Breast Cancer","volume":"26","author":"\u0130lhan","year":"2025","journal-title":"Int J Mol Sci"},{"key":"B142","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1186\/s13058-025-02029-2","article-title":"miRNA panel from HER2+ and CD24+ plasma extracellular vesicle subpopulations as biomarkers of early-stage breast cancer","volume":"27","author":"Spychalski","year":"2025","journal-title":"Breast Cancer Res: BCR"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.1002\/pros.70011","article-title":"miRNAs regulating GSTP1 as potential diagnostic biomarkers in prostate cancer","volume":"85","author":"Verma","year":"2025","journal-title":"Prostate"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1016\/j.acuroe.2025.501861","article-title":"Total quantification of circulating microRNAs and smallRNAs in plasma and urine as prognostic biomarkers in prostate cancer","volume":"501861","author":"Lorenzo-S\u00e1nchez","year":"2025","journal-title":"Actas Urol Espanolas"},{"key":"B145","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1619448","article-title":"MiRNA sequencing of platelet and exosome revealed platelet miR-199b-3p as a potential biomarker in lung adenocarcinoma","volume":"16","author":"Wen","year":"2025","journal-title":"Front Immunol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3892\/ijo.2016.3503","article-title":"Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: New trends in the development of miRNA therapeutic strategies in oncology (Review)","volume":"49","author":"Gambari","year":"2016","journal-title":"Int J Oncol"},{"key":"B147","doi-asserted-by":"publisher","first-page":"120375","DOI":"10.1016\/j.lfs.2022.120375","article-title":"Gene therapy: Comprehensive overview and therapeutic applications","volume":"294","author":"Sayed","year":"2022","journal-title":"Life Sci"},{"key":"B148","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2020.06.003","article-title":"Dual regulation of miR-34a and notch signaling in triple-negative breast cancer by antibody\/miRNA nanocarriers","volume":"21","author":"Valcourt","year":"2020","journal-title":"Mol Ther Nucleic Acids"},{"key":"B149","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.canlet.2020.12.040","article-title":"MicroRNAs: Emerging oncogenic and tumor-suppressive regulators, biomarkers and therapeutic targets in lung cancer","volume":"502","author":"Tang","year":"2021","journal-title":"Cancer Lett"},{"key":"B150","doi-asserted-by":"publisher","first-page":"101929","DOI":"10.1016\/j.mcp.2023.101929","article-title":"Current landscape of miRNAs and TGF-\u03b2 signaling in lung cancer progression and therapeutic targets","volume":"72","author":"Hussen","year":"2023","journal-title":"Mol Cell Probes"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/j.omtn.2019.02.020","article-title":"Exploring the MIR143-UPAR axis for the inhibition of human prostate cancer cells in vitro and in vivo","volume":"16","author":"Wach","year":"2019","journal-title":"Mol Ther Nucleic Acids"},{"key":"B152","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.29840","article-title":"Restoration of miR-330 expression suppresses lung cancer cell viability, proliferation, and migration","volume":"236","author":"Mohammadi","year":"2021","journal-title":"J Cell Physiol"},{"key":"B153","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/2052-8426-2-7","article-title":"microRNA therapies in cancer","volume":"2","author":"Rothschild","year":"2014","journal-title":"Mol Cell Therap"},{"key":"B154","doi-asserted-by":"publisher","first-page":"e04468","DOI":"10.1002\/smll.202504468","article-title":"Targeted Delivery of miR-34a via Anti-CD47 Antibody Conjugates for Enhanced Cancer Immunotherapy in Triple Negative Breast Cancer","volume":"21","author":"Ryu","year":"2025","journal-title":"Small (Weinheim an der Bergstrasse Germany)"},{"key":"B155","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.16350","article-title":"Reinforcement of the Tumor Suppressing Properties of microRNA-1 by Substitution at the C2\u2019 Position of Varying Ribose Residues in Chemically Synthesized microRNA-1 Molecules","volume":"43","author":"Ahrend","year":"2023","journal-title":"Anticancer Res"},{"key":"B156","doi-asserted-by":"publisher","first-page":"e13208","DOI":"10.1111\/ecc.13208","article-title":"Therapeutic potential of antagomiRs in haematological and oncological neoplasms","volume":"29","author":"Innao","year":"2020","journal-title":"Eur J Cancer Care"},{"key":"B157","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19010065","article-title":"Development of novel therapeutic agents by inhibition of oncogenic microRNAs","volume":"19","author":"Nguyen","year":"2017","journal-title":"Int J Mol Sci"},{"key":"B158","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-2823-2_12","article-title":"Guidelines on designing microRNA sponges: from construction to stable cell line","volume":"2595","author":"Ortega","year":"2023","journal-title":"Methods Mol Biol (Clifton NJ)"},{"key":"B159","doi-asserted-by":"publisher","DOI":"10.1038\/s41416-020-0802-1","article-title":"Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours","volume":"122","author":"Hong","year":"2020","journal-title":"Br J Cancer"},{"key":"B160","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31715-9","article-title":"Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomised controlled trial","volume":"389","author":"Ree","year":"2017","journal-title":"Lancet (London England)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1775016\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T05:29:48Z","timestamp":1772083788000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1775016\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,26]]},"references-count":160,"alternative-id":["10.3389\/fonc.2026.1775016"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1775016","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,26]]},"article-number":"1775016"}}